Cancer Treatment News and Research

RSS

Innovative robot automates nasal swabbing needed to diagnose COVID-19

A group of clinicians from the National Cancer Centre Singapore (NCCS), Singapore General Hospital (SGH) and Duke-NUS Medical School has partnered Biobot Surgical Pte Ltd, one of Singapore's pioneers in the field of medical robotics technology, to develop a robot that automates nasal swabbing needed to diagnose COVID-19.

23 Sep 2020

NAU researcher awarded $3.75 million NCI grant to build cancer research software

Greg Caporaso, director of the Center for Applied Microbiome Science, part of the Pathogen and Microbiome Institute at Northern Arizona University, has been awarded a $3.75 million grant by the National Cancer Institute to build software capable of analyzing and archiving data focused on the interplay between the human microbiome (the trillions of microorganisms living in and on the human body) and diverse types of cancer.

22 Sep 2020

Targeted therapy improves disease-free survival in patients with early-stage NSCLC

According to updated findings led by researchers at Yale Cancer Center, treatment with the targeted therapy osimertinib following surgery continues to significantly improve disease-free survival (DFS) in patients with early-stage, non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) gene mutations.

21 Sep 2020

Black women experience longer waits for treatment after breast cancer diagnosis, indicates study

New research suggests that Black women experience longer waits for treatment initiation than white women after a breast cancer diagnosis, and their duration of treatment is prolonged.

21 Sep 2020

Drug used to treat breast and ovarian cancer can transform treatment for prostate cancer

A drug used to treat breast and ovarian cancer can extend the lives of some men with prostate cancer and should become a new standard treatment for the disease, concludes a major trial which is set to change clinical practice.

21 Sep 2020

Enhancing the efficacy of anti-PD-L1 immunotherapy for cancer

For most people, there is no scarier diagnosis than that of cancer. While treatments including chemotherapy and radiotherapy have been used since the 1940s and late 1800s, respectively, immunotherapy has more recently emerged as a viable and successful approach to cancer treatment.

18 Sep 2020

CERN and CHUV team up to develop conceptual design of innovative radiotherapy facility

Geneva and Lausanne. CERN and the Lausanne University Hospital, in Switzerland, are collaborating to develop the conceptual design of an innovative radiotherapy facility, used for cancer treatment.

15 Sep 2020

Combined immunotherapy approaches increase the effectiveness of cancer treatment

Cancer immunotherapy is the manipulation of the immune responses naturally present in the human body to fight cancer.

11 Sep 2020

Simple blood tests can benefit women with breast cancer

A blood test that can identify a variety of mutations in advanced breast cancer can reliably match women to effective targeted treatments, early results of a major clinical trial reveal.

11 Sep 2020

Novel liver cancer treatment could shrink tumors in a mouse model

Hepatocellular carcinoma is a common liver cancer with poor prognosis. With symptoms not discovered until later stages, it is considered the most fatal malignant liver cancer worldwide.

10 Sep 2020

A novel gene involved in primary lymphedema identified

The Human Molecular Genetics laboratory of the de Duve Institute (UCLouvain), headed by Professor Miikka Vikkula, recently identified mutations in a novel gene, ANGPT2, responsible for primary lymphedema.

10 Sep 2020

New combination therapy helps fight cancer

Radiation causes key changes to immune cells in kidney cancer tumors.T cells in tumors are expanded in blood shortly after radiation, then decrease.

9 Sep 2020

New project seeks to understand the origin and role of ecDNA in cancer development

A team of pediatric oncologists led by PD Dr. Anton G. Henssen has set out to further improve our understanding of the mechanisms involved in cancer development and disease progression.

8 Sep 2020

Renowned Harley Street hospital performs pioneering dual breast surgery

King Edward VII’s Hospital – located within the Harley Street Medical Area – have announced an achievement in breast reconstruction surgery, having performed their first DIEP flap reconstruction with Lymphatic Microsurgical Healing Approach for prevention of secondary breast cancer related lymphedema.

8 Sep 2020

IU researcher receives NCI grant to study side effects of cancer treatment

A researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center has been awarded a five-year, $5.7 million National Cancer Institute grant to evaluate long-term health outcomes for cancer patients who receive platinum-based chemotherapies.

5 Sep 2020

Understanding mechanisms in prostate cancer metastases can provide treatment opportunities

An increased awareness on a molecular level of what mechanisms prostate cancer cells use to become mobile and start spreading may in the long run provide new opportunities for treatment of aggressive prostate cancer.

3 Sep 2020

Major UK study launched to assess the impact of COVID-19 on cancer patients

A new UK study has been launched to assess the impact of covid-19 on people with cancer.

2 Sep 2020

FDA grants rare disease designations to investigational brain tumor drug

The U.S. Food and Drug Administration has awarded Rare Pediatric Disease Designation (RPDD) for diffuse intrinsic pontine glioma (DIPG) and Orphan Drug Designation for treatment of malignant glioma to OKN-007, an investigational drug discovered at the Oklahoma Medical Research Foundation and being developed by Oblato, Inc.

2 Sep 2020

Existing drug masitinib identified as potential inhibitor of SARS-CoV-2

Researchers in the United States have demonstrated that a drug originally developed as a treatment for cancer exhibits antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).

2 Sep 2020

Study: BIRC2 overexpression could be a key marker for immunotherapy resistance

Johns Hopkins Medicine researchers have added to evidence that a gene responsible for turning off a cell's natural "suicide" signals may also be the culprit in making breast cancer and melanoma cells resistant to therapies that use the immune system to fight cancer.

2 Sep 2020

Cancer Treatment News and Research

Innovative robot automates nasal swabbing needed to diagnose COVID-19

NAU researcher awarded $3.75 million NCI grant to build cancer research software

Targeted therapy improves disease-free survival in patients with early-stage NSCLC

Black women experience longer waits for treatment after breast cancer diagnosis, indicates study

Drug used to treat breast and ovarian cancer can transform treatment for prostate cancer

Enhancing the efficacy of anti-PD-L1 immunotherapy for cancer

CERN and CHUV team up to develop conceptual design of innovative radiotherapy facility

Combined immunotherapy approaches increase the effectiveness of cancer treatment

Simple blood tests can benefit women with breast cancer

Novel liver cancer treatment could shrink tumors in a mouse model

A novel gene involved in primary lymphedema identified

New combination therapy helps fight cancer

New project seeks to understand the origin and role of ecDNA in cancer development

Renowned Harley Street hospital performs pioneering dual breast surgery

IU researcher receives NCI grant to study side effects of cancer treatment

Understanding mechanisms in prostate cancer metastases can provide treatment opportunities

Major UK study launched to assess the impact of COVID-19 on cancer patients

FDA grants rare disease designations to investigational brain tumor drug

Existing drug masitinib identified as potential inhibitor of SARS-CoV-2

Study: BIRC2 overexpression could be a key marker for immunotherapy resistance

Industry Focus eBook - Cell biology (5th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News